Cargando…

Vincristine dosing, drug exposure and therapeutic drug monitoring in neonate and infant cancer patients

BACKGROUND: The anticancer drug vincristine is associated with potentially dose-limiting side-effects, including neurotoxicity and myelosuppression. However, there currently exists a lack of published clinical pharmacology data relating to its use in neonate and infant patients. We report a study in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barnett, Shelby, Hellmann, Farina, Parke, Elizabeth, Makin, Guy, Tweddle, Deborah A., Osborne, Caroline, Hempel, Georg, Veal, Gareth J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science Ltd 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914346/ https://www.ncbi.nlm.nih.gov/pubmed/34657763 http://dx.doi.org/10.1016/j.ejca.2021.09.014

Ejemplares similares

Generation of evidence-based carboplatin dosing guidelines for neonates and infants
por: Barnett, Shelby, et al.
Publicado: (2023)

Clinical pharmacology of cytotoxic drugs in neonates and infants: Providing evidence-based dosing guidance
por: Nijstad, A. Laura, et al.
Publicado: (2022)

Excessive vincristine exposure in a child being treated for acute lymphoblastic leukaemia with underlying Dubin–Johnson syndrome: a case report
por: Barnett, Shelby, et al.
Publicado: (2023)

Pharmacokinetics and Pharmacogenetics of Cyclophosphamide in a Neonate and Infant Childhood Cancer Patient Population
por: Barnett, Shelby, et al.
Publicado: (2021)

Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens
por: Veal, Gareth J., et al.
Publicado: (2016)

Perspectives and Expertise in Establishing a Therapeutic Drug Monitoring Programme for Challenging Childhood Cancer Patient Populations
por: Barnett, Shelby, et al.
Publicado: (2022)

A Population Pharmacokinetic Modelling Approach to Unravel the Complex Pharmacokinetics of Vincristine in Children
por: Nijstad, A. Laura, et al.
Publicado: (2022)

Carboplatin therapeutic monitoring in preterm and full-term neonates
por: Veal, Gareth J., et al.
Publicado: (2015)

Physiologically Based Pharmacokinetic Models for Adults and Children Reveal a Role of Intracellular Tubulin Binding in Vincristine Disposition
por: Lee, Christine M., et al.
Publicado: (2019)

Modulating sensitivity to drug-induced apoptosis: the future for chemotherapy?
por: Makin, Guy, et al.
Publicado: (2001)

Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children
por: Rodieux, Frederique, et al.
Publicado: (2015)

Development of the DNA-based voltammetric biosensor for detection of vincristine as anticancer drug
por: Abbasi, Mahmoud, et al.
Publicado: (2023)

Mercaptopurine/vincristine: Drug-induced liver injury and exacerbation of drug-induced liver injury: case report
Publicado: (2022)

2535. Physiological-based pharmacokinetic analysis of drug–drug interactions between isavuconazole and vincristine in pediatric subjects
por: Choules, Mary P, et al.
Publicado: (2023)

Investigating the potential impact of dose banding for systemic anti-cancer therapy in the paediatric setting based on pharmacokinetic evidence
por: White-Koning, Melanie, et al.
Publicado: (2018)

Potentiation of vincristine by vitamin A against drug-resistant mouse leukaemia cells.
por: Nogae, I., et al.
Publicado: (1987)

Discovery of epi-Enprioline as a Novel Drug for the Treatment of Vincristine Resistant Neuroblastoma
por: Sime, Wondossen, et al.
Publicado: (2020)

Hypoxia–Induced Cytotoxic Drug Resistance in Osteosarcoma Is Independent of HIF-1Alpha
por: Adamski, Jennifer, et al.
Publicado: (2013)

Nonsteroidal Anti-Inflammatory Drugs Prevent Vincristine-Dependent Cancer-Associated Fibroblasts Formation
por: Wawro, Marta Ewelina, et al.
Publicado: (2019)

Vincristine-Induced Seizure from Drug Interactions: A Case Report and Review of Literature
por: Heidari, Shima, et al.
Publicado: (2023)

Marqibo(®) (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
por: Silverman, Jeffrey A., et al.
Publicado: (2012)

Pharmacokinetics and Safety of a Novel Oral Liquid Formulation of 13-cis Retinoic Acid in Children with Neuroblastoma: A Randomized Crossover Clinical Trial
por: Veal, Gareth J., et al.
Publicado: (2021)

Activity of high-dose cis-platinum (NCI 119875) in combination with vincristine and methotrexate in drug-resistant gestational choriocarcinoma. A report of 17 cases.
por: Newlands, E. S., et al.
Publicado: (1979)

Clinical Analysis of Adverse Drug Reactions between Vincristine and Triazoles in Children with Acute Lymphoblastic Leukemia
por: Yang, Lihua, et al.
Publicado: (2015)

Removal of two cytostatic drugs: bleomycin and vincristine by white-rot fungi – a sorption study
por: Jureczko, Marcelina, et al.
Publicado: (2021)

Vincristine, adriamycin and high dose steroids in myeloma complicated by renal failure.
por: Aitchison, R. G., et al.
Publicado: (1990)

Platelet number and function in response to a single intravenous dose of vincristine
por: Allen, Erin C., et al.
Publicado: (2021)

Cocktail therapy with prednisolone, vincristine and sirolimus for Kasabach‑Merritt phenomenon in 10 infants
por: Liu, Qianlong, et al.
Publicado: (2022)

Lymphoma-targeted treatment using a folic acid-decorated vincristine-loaded drug delivery system
por: Qiu, Lei, et al.
Publicado: (2018)

Vincristine-Induced Cranial Neuropathy
por: TALEBIAN, Ahmad, et al.
Publicado: (2014)

Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study
por: Amoroso, Loredana, et al.
Publicado: (2018)

Identification of small molecules that mitigate vincristine‐induced neurotoxicity while sensitizing leukemia cells to vincristine
por: Diouf, Barthelemy, et al.
Publicado: (2021)

Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy
por: Hatzl, Stefan, et al.
Publicado: (2021)

Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients
por: van de Velde, Mirjam E., et al.
Publicado: (2022)

Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study
por: Casanova, Michela, et al.
Publicado: (2023)

Dose‐Related Adverse Drug Events in Neonates: Recognition and Assessment
por: Allegaert, Karel, et al.
Publicado: (2021)

Vincristine-Induced Peripheral Neuropathy in Children With Malignancy and the Effect of Missed Doses on Treatment Success
por: Eker, Nurşah, et al.
Publicado: (2023)

Vincristine-Induced Neuropathy in Patients Diagnosed with Solid and Hematological Malignancies: The Role of Dose Rounding
por: Alwhaibi, Abdulrahman M., et al.
Publicado: (2023)

Approaches to Dose Finding in Neonates, Illustrating the Variability between Neonatal Drug Development Programs
por: Van den Anker, John N., et al.
Publicado: (2020)

Production of IL-1β by bone marrow-derived macrophages in response to chemotherapeutic drugs: Synergistic effects of doxorubicin and vincristine
por: Wong, John, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a17acqhvs5enis84sh45jqaho6